Global Retinal Vein Occlusion Market, By Type (Branch Retinal Artery Occlusion, Central Retinal Vein Occlusion), Condition (Non-Ischemic, Ischemic), Diagnosis (Optical Coherence Tomography (OCT), Fundoscopic Examination, Fluorescein Angiography, Others), Treatment (Antivascular Endothelial Growth Factor, Corticosteroid Drugs, Laser Retinal Photocoagulation, Others), End User (Hospitals and Clinics, Research and Academics, Others) Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Retinal Vein Occlusion Market
Retinal vein occlusion market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 10.70% in the above mentioned forecast period and is likely to reach USD 27,297.9 million by 2029.
Retinal vein occlusion is a medical condition wherein the interference of veins that are liable for blood transportation from the vein to the centre for pumping and purification gets blocked. This blockage causes vision loss and if left untreated may result in permanent vision loss. The retina is responsible for converting the images captured by the eye in the form of light which is subsequently converted into nerve signals that facilitate the individual to understand images and objects.
Increasing prevalence of diabetes and atherosclerosis is the major factor accelerating the growth of the retinal vein occlusion market. Furthermore, significant changes across the lifestyle of individuals and rising volume of patients suffering from myeloma, lymphoma and glaucoma are also expected to drive the growth of the retinal vein occlusion market. However, concerns regarding treatment methods for this disorder restrains the retinal vein occlusion market. Also, high cost of treatment will challenge market growth.
In addition, increasing number of individuals are opting for remote health services which will create ample opportunities for the retinal vein occlusion market.
This retinal vein occlusion market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the retinal vein occlusion market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Retinal Vein Occlusion Market Scope and Market Size
The retinal vein occlusion market is segmented on the basis of type, condition, diagnosis, treatment and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the retinal vein occlusion market is segmented into branch retinal artery occlusion and central retinal vein occlusion.
- On the basis of condition, the retinal vein occlusion market is segmented into non-ischemic and ischemic.
- On the basis of diagnosis, the retinal vein occlusion market is segmented as optical coherence tomography (OCT), fundoscopic examination, fluorescein angiography and others.
- On the basis of treatment, the retinal vein occlusion market is categorized into antivascular endothelial growth factor, corticosteroid drugs, laser retinal photocoagulation and others.
- Retinal vein occlusion market is also segmented on the basis of end user into hospitals and clinics, research and academics and others.
Retinal Vein Occlusion Market Country Level Analysis
Retinal vein occlusion market is analyzed and market size information is provided by the country, type, condition, diagnosis, treatment and end user as referenced above.
The countries covered in the retinal vein occlusion market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the retinal vein occlusion market because majority of the market share owing to the significant prevalence of diabetic population resulting in increased incidences for retinal disorders in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the growth of diabetic population in the region in the region.
The country section of the retinal vein occlusion market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Retinal vein occlusion market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the retinal vein occlusion market report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the retinal vein occlusion market in the growth period.
Competitive Landscape and Global Retinal Vein Occlusion Market Share Analysis
Retinal vein occlusion market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global retinal vein occlusion market research.
Some of the major players operating in the retinal vein occlusion market are Allergan, Bayer AG, IRIDEX Corporation, Lumenis, Novartis AG, NIDEK CO., LTD., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Topcon Corporation, Merck & Co., Inc., Carl Zeiss AG, Alimera Sciences, Annexin Pharmaceuticals, Amgen Inc., Cangene Corporation, BD, Bosch Healthcare Solutions GmbH, Baxter and Novartis AG among others.
SKU-